Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC (PembroRad)

Clinical Trial ID NCT02707588

PubWeight™ 2.32‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02707588

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology 2016 0.81
2 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
3 Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2016 0.75
Next 100